1. Home
  2. AOUT vs ALXO Comparison

AOUT vs ALXO Comparison

Compare AOUT & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Outdoor Brands Inc.

AOUT

American Outdoor Brands Inc.

HOLD

Current Price

$12.95

Market Cap

176.9M

Sector

Industrials

ML Signal

HOLD

Logo ALX Oncology Holdings Inc.

ALXO

ALX Oncology Holdings Inc.

HOLD

Current Price

$2.03

Market Cap

205.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AOUT
ALXO
Founded
2020
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Ordnance And Accessories
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
176.9M
205.9M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
AOUT
ALXO
Price
$12.95
$2.03
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$12.50
$3.50
AVG Volume (30 Days)
198.0K
1.6M
Earning Date
03-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.36
EPS
N/A
N/A
Revenue
$190,536,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$8.06
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.26
$0.51
52 Week High
$14.97
$2.66

Technical Indicators

Market Signals
Indicator
AOUT
ALXO
Relative Strength Index (RSI) 52.67 53.04
Support Level $8.04 $1.96
Resistance Level $14.97 $2.31
Average True Range (ATR) 0.72 0.17
MACD -0.24 -0.02
Stochastic Oscillator 19.12 28.43

Price Performance

Historical Comparison
AOUT
ALXO

About AOUT American Outdoor Brands Inc.

American Outdoor Brands Inc is the provider of outdoor lifestyle products and shooting sports accessories encompassing hunting, fishing, meat processing, outdoor cooking, shooting, and personal security and defense products for rugged outdoor enthusiasts. It conceive, design, produce or source, and sell its outdoor lifestyle products including premium sportsman knives, land management tools, products used while hunting, meat processing equipment; and outdoor cooking products and hooting sports accessories, including rests, vaults, and other related accessories, electro-optical devices, including hunting optics, firearm aiming devices, flashlights, and laser grips, etc. The company operate as one reporting segment.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: